Recombinant C. Difficile A Toxin (Actoxumab Biosimilar) antibody

Catalog No. ABIN7538088

The Human Monoclonal anti-C. Difficile A Toxin (Actoxumab Biosimilar) antibody is suitable to detect C. Difficile A Toxin (Actoxumab Biosimilar) in samples from Clostridium difficile. It has been validated for ELISA and WB.

Quick Overview for Recombinant C. Difficile A Toxin (Actoxumab Biosimilar) antibody (ABIN7538088)

Target: C. Difficile A Toxin (Actoxumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Clostridium difficile

Host: Human

Clonality: Monoclonal

Conjugate: This C. Difficile A Toxin (Actoxumab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-C. Difficile A Toxin (Actoxumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Actoxumab Biosimilar – Anti-C. Difficile toxin A mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for C. Difficile A Toxin (Actoxumab Biosimilar)

Target: C. Difficile A Toxin (Actoxumab Biosimilar)

Target Type: Biosimilar

Background: Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab targeting TcdB.

CAS-No: 1245634-25-6